2022
Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample
Jegede O, Rhee TG, Stefanovics EA, Zhou B, Rosenheck RA. Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample. Psychiatry Research 2022, 315: 114720. PMID: 35834863, DOI: 10.1016/j.psychres.2022.114720.Peer-Reviewed Original ResearchConceptsSubstance use disordersDual diagnosisPsychiatric disordersIndependent correlatesUse disordersDrug use diagnosesService use characteristicsPoor mental HRQOLRelated Conditions Wave IIINational Epidemiologic SurveyRepresentative US sampleMental HRQOLSUD diagnosisUse diagnosesTreatment needsEpidemiologic SurveyWave IIIAdult traumaMedical problemsSuicide attemptsDiagnosisDisordersAdultsFurther studiesSocial support
2021
Lifetime risk and correlates of incarceration in a nationally representative sample of U.S. adults with non-substance-related mental illness
Nakic M, Stefanovics EA, Rhee TG, Rosenheck RA. Lifetime risk and correlates of incarceration in a nationally representative sample of U.S. adults with non-substance-related mental illness. Social Psychiatry And Psychiatric Epidemiology 2021, 57: 1839-1847. PMID: 34453553, DOI: 10.1007/s00127-021-02158-x.Peer-Reviewed Original ResearchConceptsBehavioral risk factorsSubstance use disordersDSM-5 disordersMental illnessRisk factorsPsychiatric disordersUse disordersLifetime historyCorrelates of incarcerationMethodsNationally representative dataLogistic regression analysisNational Epidemiologic SurveyRelated Conditions-IIIBorderline personality disorderAntisocial personality disorderProportion of respondentsResultsAmong adultsIndependent associationLifetime riskUS adultsDual diagnosisEpidemiologic SurveyDiagnostic groupsIllnessU.S. adults
2018
Polysubstance Use Among Veterans in Intensive PTSD Programs: Association With Symptoms and Outcomes Following Treatment
Bhalla IP, Stefanovics EA, Rosenheck RA. Polysubstance Use Among Veterans in Intensive PTSD Programs: Association With Symptoms and Outcomes Following Treatment. Journal Of Dual Diagnosis 2018, 15: 36-45. PMID: 30444189, DOI: 10.1080/15504263.2018.1535150.Peer-Reviewed Original ResearchConceptsPolysubstance useTotal daysSubstance usePTSD symptomsInnovative trial designsAddictive substancesPolysubstance use disorderMore total daysSevere PTSD symptomsBaseline characteristicsSuch patientsPTSD symptom severitySevere symptomsUse disordersDual diagnosisTrial designDifferent addictive substancesDisorders ProgramPosttraumatic Stress Disorder (CR for PTSD) programPatientsComplex interventionsSimilar associationBivariate analysisPTSD programSymptom severityMental health multimorbidity and poor quality of life in patients with schizophrenia
Bhalla IP, Stefanovics EA, Rosenheck RA. Mental health multimorbidity and poor quality of life in patients with schizophrenia. Schizophrenia Research 2018, 201: 39-45. PMID: 29709490, DOI: 10.1016/j.schres.2018.04.035.Peer-Reviewed Original ResearchConceptsAdditional psychiatric comorbiditySubstance use disordersPsychiatric comorbidityPsychiatric disordersUse disordersMental health multimorbiditySubstance use comorbiditiesAdditional psychiatric disordersComorbid psychiatric disordersComorbid substance useComplex clinical presentationClinical Antipsychotic TrialsSelf-reported QoLSimilar adverse effectsMultimorbidity frameworkPoor qualityClinical presentationWorse QoLBetter QOLAntipsychotic TrialsComorbiditiesDual diagnosisQoLPatientsMultimorbidity